Prenatal assessment of fetal chromosomal and genetic disorders through maternal plasma DNA analysis

Pathology

Volumn 44, Issue 2, 2012, Pages 69-72

  Liao, Gary J W ^a,b   Chiu, Rossa W K ^a,b   Dennis Lo, Y M ^a,b  

^a Li Ka Shing Institute of Health Sciences   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cell free fetal DNA; Non invasive prenatal screening; RHD genotyping; Sex assessment; T21 screening

Indexed keywords

EID: 84858319839     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e32834e8e29     Document Type: Article

References (57)

1. Wald N, Leck I. Antenatal and Neonatal Screening. 2nd ed. Oxford: Oxford University Press; 2000; 1-57.
2. Driscoll DA, Gross S. Prenatal screening for aneuploidy. N Engl J Med 2009; 360: 2556-62.
3. Mujezinovic F, Alfirevic Z. Procedure-related complications of amnio-centesis and chorionic villous sampling - A systematic review. Obstet Gynecol 2007; 110: 687-94. (Pubitemid 47359597)
4. Bianchi DW, Flint AF, Pizzimenti MF, et al. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci USA 1990; 87: 3279-83. (Pubitemid 20173618)
5. Bianchi DW, Williams JM, Sullivan LM, et al. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 1997; 61: 822-9. (Pubitemid 27418456)
6. Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27years postpartum. Proc Natl Acad Sci USA 1996; 93: 705-8. (Pubitemid 26041153)
7. Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-7. (Pubitemid 27343304)
8. Alberry M, Maddocks D, Jones M, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 2007; 27: 415-8. (Pubitemid 47164339)
9. Chan KCA, Ding CM, Gerovassili A, et al. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006; 52: 2211-8. (Pubitemid 44924994)
10. Chim SSC, Tong YK, Chiu RWK, et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 2005; 102: 14753-8. (Pubitemid 41457128)
11. Chiu RWK, Chim SSC, Wong IHN, et al. Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 2007; 170: 941-50. (Pubitemid 47339363)
12. Flori E, Doray B, Gautier E, et al. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Hum Reprod 2004; 19: 723-4. (Pubitemid 38344540)
13. Rijnders RJP, Van der Luijt RB, Peters EDJ, et al. Earliest gestational age for fetal sexing in cell-free maternal plasma. Prenat Diagn 2003; 23: 1042-4. (Pubitemid 38084143)
14. Lun FMF, Chiu RWK, Chan KCA, et al. Microfluidics digital PCR reveals a higher than expected fraction offetal DNA inmaternal plasma. Clin Chem 2008; 54: 1664-72.
15. Hill M, Finning K, Martin P, et al. Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet 2010; 80: 68-75.
16. Lo YMD, Zhang J, Leung TN, et al. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999; 64: 218-24. (Pubitemid 30428975)
17. Lo YMD, Chan KCA, Sun H, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010; 2: 61-91.
18. Finning KM, Chitty LS. Non-invasive fetal sex determination: Impact on clinical practice. Semin Fetal Neonatal Med 2008; 13: 69-75.
19. Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood - A meta-analysis. Am J Obstet Gynecol 2006; 195: 1163-73. (Pubitemid 44415679)
20. Chiu RWK, Cantor CR, Lo YMD. Non-invasive prenatal diagnosis by single molecule counting technologies. Trends Genet 2009; 25: 324-331.
21. Harvey GK, David JA. Mollison's Blood Transfusion in Clinical Medicine. 11th ed. Oxford: Blackwell; 2005; 163-208.
22. National Institute for Clinical Excellence (NICE). Technology Appraisal Guidance 41. Guidance on the Use of Routine Antenatal Anti-D Prophylaxis for RhD-negative Women. London: NICE, 2002.
23. Daniels G. Human Blood Groups. 2nd ed. Oxford: Blackwell Science; 2002; 195-274.
24. Bennett PR, Kim CL, Colin Y, et al. Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med 1993; 329: 607-10. (Pubitemid 23244811)
25. Lo YMD, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998; 339: 1734-8. (Pubitemid 28555431)
26. Van der Schoot CE, Soussan AA, Koelewijn J, et al. Non-invasive antenatal RHD typing. Transfus Clin Biol 2006; 13: 53-7.
27. Finning K, Martin P, Summers J, et al. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immuno-globulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008; 336: 816-8. (Pubitemid 351548224)
28. Muller SP, Bartels I, Stein W, et al. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 2008; 48: 2292-301.
29. Maddocks DG, Alberry MS, Attilakos G, et al. The SAFE project: towards non-invasive prenatal diagnosis. Biochem Soc Trans 2009; 37: 460-5.
30. Van der Schoot CE, Rijnders RJP, Bossers B, et al. Real time PCR of bi-allelic insertion/deletion polymorphisms can serve as a reliable positive control for cell-free fetal DNA in non-invasive prenatal genotyping. Blood 2003; 102: 315.
31. Stephens JD, Sherman S. Determination of fetal sex by ultrasound. N Engl J Med 1983; 309: 984. (Pubitemid 13008971)
32. Whitlow BJ, Lazanakis MS, Economides DL. The sonographic identification of fetal gender from 11 to 14 weeks of gestation. Ultrasound Obstet Gynecol 1999; 13: 301-4. (Pubitemid 29312635)
33. Ammini AC, Sabherwal U, Mukhopadhyay C, et al. Morphogenesis of the human external male genitalia. Pediatr Surg Int 1997; 12: 401-406. (Pubitemid 27322816)
34. Odeh M, Grinin V, Kais M, et al. Sonographic fetal sex determination. Obstet Gynecol Surv 2009; 64: 50-7.
35. Lee CA, Chi C, Pavord SR, et al. The obstetric and gynaecological management of women with inherited bleeding disorders - review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization. Haemophilia 2006; 12: 301-36.
36. Costa JM, Benachi A, Gautier E. New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 2002; 346: 1502. (Pubitemid 34755726)
37. Hyett JA, Gardener G, Stojilkovic-Mikic T, et al. Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn 2005; 25: 1111-6. (Pubitemid 43016291)
38. Santacroce R, Vecchione G, Tomaiyolo M, et al. Identification of fetal gender in maternal blood is a helpful tool in the prenatal diagnosis of haemophilia. Haemophilia 2006; 12: 417-22.
39. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005; 365: 2125-36. (Pubitemid 40826971)
40. Speiser PW, Azziz R, Baskin LS, et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010; 95: 4133-60.
41. Nimkarn S, New MI. Prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Mol Cell Endocrinol 2009; 300: 192-6.
42. Bartha JL, Finning K, Soothill PW. Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency. Obstet Gynecol 2003; 101: 1135-6. (Pubitemid 36566404)
43. Hill M, Taffinder S, Chitty LS, Morris S. Incremental cost of non-invasive prenatal diagnosis versus invasive prenatal diagnosis of fetal sex in England. Prenat Diagn 2011; 31: 267-73.
44. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007; 109: 217-227.
45. Lo YMD, Tsui NBY, Chiu RWK, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007; 13: 218-23.
46. Tong YK, Ding CM, Chiu RWK, et al. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. Clin Chem 2006; 52: 2194-202. (Pubitemid 44924992)
47. Tong YK, Jin SN, Chiu RWK, et al. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem 2010; 56: 90-8.
48. Tsui NBY, Akolekar R, Chiu RWK, et al. Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin Chem 2010; 56: 73-81.
49. Zimmermann B, Holzgreve W, Wenzel F, et al. Novel real-time quantitative PCR test for trisomy 21. Clin Chem 2002; 48: 362-3. (Pubitemid 34107277)
50. Lo YMD, Lun FMF, Chan KCA, et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 2007; 104: 13116-21. (Pubitemid 351737602)
51. Chiu RWK, Chan KCA, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNAin maternal plasma. Proc Natl Acad Sci USA 2008; 105: 20458-63.
52. Chiu RWK, Sun H, Akolekar R, et al. Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem 2010; 56: 459-63.
53. Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008; 105: 16266-71.
54. Chiu RWK, Akolekar R, Zheng YWL, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011; 342: c7401.
55. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011; 204: 205 e1-205 e11.
56. Finning KM, Martin PG, Soothill PW,et al. Prediction offetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002; 42: 1079-85.
57. Chen EZ, Chiu RWK, Sun H, et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011; 6: e21791.